Rising Prevalence Of Head And Neck Cancer To Drive Market Growth Driving Market Acceleration in the Head And Neck Cancer Diagnostics Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Head And Neck Cancer Diagnostics Market Size By 2025?
The size of the market for diagnostics in head and neck cancer has seen a swift expansion in the recent past. The market, which is set to escalate from $1.74 billion in 2024 to $2.05 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 17.4%. The significant progression in the historical phase is a result of factors like tobacco and alcohol usage, an escalating elderly population, awareness initiatives, evolution in biopsy methods, and enhancement in healthcare infrastructure.

How Big Is the Head And Neck Cancer Diagnostics Market Size Expected to Grow by 2029?
The market size for diagnostics in head and neck cancer is anticipated to experience quick growth in the coming years. The value is predicted to reach $3.87 billion in 2029, with a compound annual growth rate (CAGR) of 17.3%. The surge during the forecast period could be credited to factors like genomic biomarkers, a growing number of hpv-related cancers, the incorporation of artificial intelligence (AI), immunotherapy, targeted therapies and changes in healthcare policies and reimbursements. Key trends during the projected period are the prominence of liquid biopsy, multi-modality diagnostics, point-of-care diagnostics, global alliances and collaborations, and the integration of digital pathology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-diagnostics-global-market-report

Which Key Market Drivers Powering Head And Neck Cancer Diagnostics Market Expansion and Growth?
The anticipated surge in head and neck cancer cases is set to boost the expansion of the head and neck cancer diagnostics market. Head and neck cancer encompasses a variety of tumors that target tissues and organs in the head and neck region, such as the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. Diagnostic tools for head and neck cancer aim to identify the disease at a nascent stage using tests like incisional biopsy and barium swallow test. According to a report by the American Society of Clinical Oncology in February 2023, a professional organization for physicians and oncology professionals based in the US, head and neck cancer constitutes 4% of all US malignancies. It's projected to impact 66,920 individuals in the US by 2023, of which 49,190 will be men and 17,730 women. Globally, head and neck cancer affected 562,328 people in 2020. The data from Australia's head and neck cancer statistics show that in 2022, there were 5,189 newly diagnosed cases. The escalating rate of head and neck cancer, therefore, propels the advancement of the head and neck cancer diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12016&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Head And Neck Cancer Diagnostics Market?
Innovating new products has recently become a significant trend in the head and neck cancer diagnosis market. Most major market participants are focusing their energy on developing revolutionary products to fortify their market standing. For instance, in May 2023, Cetuxa, the first globally biosimilar for head and neck cancer treatment was introduced by Alkem Laboratories Ltd, a healthcare organization based in India. Cetuxa mirrors cetuximab, a monoclonal antibody that obstructs receptor-based transduction paths and exhibits anti-cancer properties. Cetuximab is affixed to the outer domain of the epidermal growth factor receptor (EGFR). Cetuximab is often used in combination with radiation treatment or chemotherapy. It presents a potential treatment for locally advanced, recurring, or metastasized Squamous cell carcinoma of the head and neck.

What Are the Emerging Segments in the Head And Neck Cancer Diagnostics Market?
The head and neck cancer diagnostics market covered in this report is segmented -

1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods
2) By Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Diagnostic Centers, Other End Users

Subsegments:
1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, X-rays
2) By Endoscopy Screening Equipment: Rigid Endoscopes, Flexible Endoscopes, Video Endoscopy Systems
3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Dental Diagnostic Methods: Intraoral Cameras, Dental X-rays, Oral Cancer Screening Devices
5) By Other Diagnostic Methods: Molecular Diagnostics, Blood Tests, Genetic Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12016&type=smp

Who Are the Global Leaders in the Head And Neck Cancer Diagnostics Market?
Major companies operating in the head and neck cancer diagnostics market include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc, Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., VolitionRx Ltd.

Which are the Top Profitable Regional Markets for the Head And Neck Cancer Diagnostics Industry?
North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12016

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.